Results 81 to 90 of about 33,313 (208)

Pharmacokinetic and Pharmacodynamic Evaluation of a Weight-Based Dosing Regimen of Cefoxitin for Perioperative Surgical Prophylaxis in Obese and Morbidly Obese Patients

Antimicrobial Agents and Chemotherapy, 2016
P. Moine, S. Mueller, J. Schoen, Kevin Rothchild, D. Fish   +4 more
semanticscholar   +1 more source

The Brief Case: Adjudication of discrepant genotypic and phenotypic antimicrobial susceptibility testing results in a patient with <i>Staphylococcus aureus</i> bacteremia. [PDF]

J Clin Microbiol
Reyes Curcio F, McCallum J, Borrelli G, Orr B, Weiss Z, Nussbaum EZ.   +5 more
europepmc   +1 more source

Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy.

Clinical Therapeutics, 2016
L. Brunetti, L. Kagan, G. Forrester, L. Aleksunes, Hongxia Lin, S. Buyske, R. Nahass   +6 more
semanticscholar   +1 more source

Differences in β-lactamase activity and carbapenem resistance among the <i>Bacillus cereus</i> group. [PDF]

Antimicrob Agents Chemother
Nishihara Y, Nakano R, Nakano A, Suzuki Y, Ogawa M, Sakata R, Yano H, Kasahara K.   +7 more
europepmc   +1 more source

Genetic and clinical landscape of methicillin-resistant Staphylococcus aureus isolates lacking the mec gene, in Japan. [PDF]

JAC Antimicrob Resist
Natori T, Nagano Y, Denda T, Higuma Y, Matsumoto T, Ishimine N, Uehara T, Nagano N.   +7 more
europepmc   +1 more source

Evaluation of Oxacillin and Cefoxitin Disk and MIC Breakpoints for Prediction of Methicillin Resistance in Human and Veterinary Isolates of Staphylococcus intermedius Group

Journal of Clinical Microbiology, 2015
Max T. Wu, Max T. Wu, CA Burnham, Lars F. Westblade, J. D. Bard, S. Lawhon, Meghan A. Wallace, T. Stanley, Eileen M. Burd, J. Hindler, R. Humphries   +10 more
semanticscholar   +1 more source

Re-examining cephalosporin activity against methicillin-susceptible <i>Staphylococcus aureus</i> among clinical isolates from southern Taiwan. [PDF]

JAC Antimicrob Resist
Lin YT, Kuo SF, Chien CC, Hung CH, Ming HY, Huang TY, Lee CH.   +6 more
europepmc   +1 more source

In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex.

Clinical Microbiology and Infection, 2014
M. Lavollay, V. Dubée, B. Heym, J. Herrmann, J. Gaillard, L. Gutmann, M. Arthur, J. Mainardi   +7 more
semanticscholar   +1 more source

Methicillin-resistant <i>Staphylococcus lugdunensis</i> in a neonatal intensive care unit: diagnostic challenges and emergence of multidrug-resistance. [PDF]

Front Med (Lausanne)
Smith MH, Rønning TG, Rettedal SI, Enger H, Löhr IH, Sundal J, Vatne A, Syre H, Ås CG.   +8 more
europepmc   +1 more source

Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.

Clinical Infectious Diseases, 2014
J. Dien Bard, J. Hindler, H. Gold, B. Limbago   +3 more
semanticscholar   +1 more source